Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rakovina Therapeutics Inc. has partnered with Variational AI to research and develop new cancer treatments utilizing AI-driven drug discovery platforms. The collaboration will focus on identifying novel small-molecule therapies targeting DNA-damage response for cancer treatment, with Rakovina Therapeutics synthesizing and evaluating drug candidates at the University of British Columbia labs.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
